AU2001245354A1 - Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies - Google Patents

Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies

Info

Publication number
AU2001245354A1
AU2001245354A1 AU2001245354A AU4535401A AU2001245354A1 AU 2001245354 A1 AU2001245354 A1 AU 2001245354A1 AU 2001245354 A AU2001245354 A AU 2001245354A AU 4535401 A AU4535401 A AU 4535401A AU 2001245354 A1 AU2001245354 A1 AU 2001245354A1
Authority
AU
Australia
Prior art keywords
serine
polypeptides
antibodies
threonine phosphatase
phosphatase polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245354A
Inventor
Reinhard Ebner
Steven M Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2001245354A1 publication Critical patent/AU2001245354A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/03Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03016Phosphoprotein phosphatase (3.1.3.16), i.e. calcineurin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001245354A 2000-03-02 2001-02-28 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies Abandoned AU2001245354A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18635000P 2000-03-02 2000-03-02
US60186350 2000-03-02
PCT/US2001/006256 WO2001064703A1 (en) 2000-03-02 2001-02-28 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies

Publications (1)

Publication Number Publication Date
AU2001245354A1 true AU2001245354A1 (en) 2001-09-12

Family

ID=22684599

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245354A Abandoned AU2001245354A1 (en) 2000-03-02 2001-02-28 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies

Country Status (6)

Country Link
US (1) US20020160493A1 (en)
EP (1) EP1259525A1 (en)
JP (1) JP2003525057A (en)
AU (1) AU2001245354A1 (en)
CA (1) CA2397502A1 (en)
WO (1) WO2001064703A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1294897A2 (en) * 2000-05-19 2003-03-26 Millennium Pharmaceuticals, Inc. 21910, a membrane-associated guanylate kinase and uses thereof
AU2002235173A1 (en) * 2000-11-03 2002-05-15 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
US20020150924A1 (en) * 2000-11-21 2002-10-17 Susana Salceda Compositions and methods relating to prostate specific genes and proteins
WO2005050217A1 (en) * 2003-11-12 2005-06-02 Roche Diagnostics Gmbh Use of protein pspase as a marker for breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9304769A (en) * 1992-08-05 1994-05-31 Max Planck Gesellschaft PTP-D SUBFAMILY OF THYROSINE PROTEIN PHOSPHATASES.
US5585233A (en) * 1993-03-23 1996-12-17 Max-Planck Gesellschaft Zur Forderung Der Wissenschaften E.V. PTP-S31: A novel protein tyrosine phosphatase
DE19611234C1 (en) * 1996-03-21 1997-11-20 Deutsches Krebsforsch Tyrosine phosphatase-related protein
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx

Also Published As

Publication number Publication date
JP2003525057A (en) 2003-08-26
WO2001064703A1 (en) 2001-09-07
EP1259525A1 (en) 2002-11-27
CA2397502A1 (en) 2001-09-07
US20020160493A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
AU2001233156A1 (en) Bcl-2-like polynucleotides, polypeptides, and antibodies
AU2001271714A1 (en) B7-like polynucleotides, polypeptides, and antibodies
AU2001240819A1 (en) Proteomics database
AU2413401A (en) Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
AU1924101A (en) Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies
AU2001269906A1 (en) Methods for immobilizing polypeptides
AU1685600A (en) Polypeptides
AU3075801A (en) Transferrin polynucleotides, polypeptides, and antibodies
AU1191001A (en) Plasminogen-like polynucleotides, polypeptides, and antibodies
AU2001253323A1 (en) Extracellular matrix polynucleotides, polypeptides, and antibodies
AUPQ976800A0 (en) Novel polypeptides and polynucleotides and uses therefor
AU1582401A (en) Uteroglobin-like polynucleotides, polypeptides, and antibodies
AU7335400A (en) Attractin-like polynucleotides, polypeptides, and antibodies
AU6049399A (en) Serine/threonine protein kinases
AU2002330672A1 (en) Gmg-1 polynucleotides and polypeptides and uses thereof
AU2002241899A1 (en) Tip39 polypeptides
AU2001241611A1 (en) Adam polynucleotides, polypeptides, and antibodies
AU2001238585A1 (en) Human polynucleotides, polypeptides, and antibodies
AU2001241610A1 (en) Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
AU4001000A (en) Dwf4 polynucleotides, polypeptides and uses thereof
AU2001245354A1 (en) Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
AU2590201A (en) Trefoil domain-containing polynucleotides, polypeptides, and antibodies
AU2002351469A1 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
AU2001274676A1 (en) Plant-signalling ligand like proteins
EP1212415A4 (en) Pgrp-l polynucleotides, polypeptides, and antibodies